Skip to Main Content

Paper Details

Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas.
J Neurooncol
9
2019
Author NameAffiliation
Thomas J KaleyMemorial Sloan Kettering Cancer Center
  • 1 - 1

Datasets

Release 1.2